Dr Jared E Duncan, MD | |
21 Worthen Rd, Lexington, MA 02421-4835 | |
(781) 862-1620 | |
Not Available |
Full Name | Dr Jared E Duncan |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 15 Years |
Location | 21 Worthen Rd, Lexington, Massachusetts |
Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215165352 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207WX0110X | Ophthalmology - Pediatric Ophthalmology And Strabismus Specialist | 291503 (Massachusetts) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Lexington Eye Associates, Inc | 5698748986 | 33 |
Lexington Eye Associates - Bid | 8820315682 | 30 |
News Archive
Genetics researchers have identified a key gene that, when mutated, causes the rare multisystem disorder Cornelia deLange syndrome (CdLS). By revealing how mutations in the HDAC8 gene disrupt the biology of proteins that control both gene expression and cell division, the research sheds light on this disease, which causes intellectual disability, limb deformations and other disabilities resulting from impairments in early development.
The Hill reports that delaying a scheduled pay cut for one year to doctors who treat Medicare patients would cost $25 billion.
Insomnia is a common problem in patients with schizophrenia, and a new study reinforces a close association between insomnia, more suicidal thoughts and actions and increased problems like anxiety and depression in these patients.
Following media reports of children with epilepsies reportedly deriving benefits from medical marijuana (or cannabis-based medicinal products) accessed abroad, the UK government allowed clinicians to prescribe these products.
Allergan plc, a leading global pharmaceutical company, today announced that its wholly owned subsidiary has entered into an exclusive licensing agreement with Mimetogen Pharmaceuticals, a clinical stage biotechnology company, to develop and commercialize tavilermide (MIM-D3), a topical formulation of a novel small molecule TrkA agonist for the treatment of dry eye disease.
› Verified 9 days ago
Entity Name | Lexington Eye Associates, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467502757 PECOS PAC ID: 5698748986 Enrollment ID: O20040816000511 |
News Archive
Genetics researchers have identified a key gene that, when mutated, causes the rare multisystem disorder Cornelia deLange syndrome (CdLS). By revealing how mutations in the HDAC8 gene disrupt the biology of proteins that control both gene expression and cell division, the research sheds light on this disease, which causes intellectual disability, limb deformations and other disabilities resulting from impairments in early development.
The Hill reports that delaying a scheduled pay cut for one year to doctors who treat Medicare patients would cost $25 billion.
Insomnia is a common problem in patients with schizophrenia, and a new study reinforces a close association between insomnia, more suicidal thoughts and actions and increased problems like anxiety and depression in these patients.
Following media reports of children with epilepsies reportedly deriving benefits from medical marijuana (or cannabis-based medicinal products) accessed abroad, the UK government allowed clinicians to prescribe these products.
Allergan plc, a leading global pharmaceutical company, today announced that its wholly owned subsidiary has entered into an exclusive licensing agreement with Mimetogen Pharmaceuticals, a clinical stage biotechnology company, to develop and commercialize tavilermide (MIM-D3), a topical formulation of a novel small molecule TrkA agonist for the treatment of dry eye disease.
› Verified 9 days ago
Entity Name | Lexington Eye Associates - Bid |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1801204714 PECOS PAC ID: 8820315682 Enrollment ID: O20150317000159 |
News Archive
Genetics researchers have identified a key gene that, when mutated, causes the rare multisystem disorder Cornelia deLange syndrome (CdLS). By revealing how mutations in the HDAC8 gene disrupt the biology of proteins that control both gene expression and cell division, the research sheds light on this disease, which causes intellectual disability, limb deformations and other disabilities resulting from impairments in early development.
The Hill reports that delaying a scheduled pay cut for one year to doctors who treat Medicare patients would cost $25 billion.
Insomnia is a common problem in patients with schizophrenia, and a new study reinforces a close association between insomnia, more suicidal thoughts and actions and increased problems like anxiety and depression in these patients.
Following media reports of children with epilepsies reportedly deriving benefits from medical marijuana (or cannabis-based medicinal products) accessed abroad, the UK government allowed clinicians to prescribe these products.
Allergan plc, a leading global pharmaceutical company, today announced that its wholly owned subsidiary has entered into an exclusive licensing agreement with Mimetogen Pharmaceuticals, a clinical stage biotechnology company, to develop and commercialize tavilermide (MIM-D3), a topical formulation of a novel small molecule TrkA agonist for the treatment of dry eye disease.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jared E Duncan, MD 21 Worthen Rd, Lexington, MA 02421-4835 Ph: (781) 862-1620 | Dr Jared E Duncan, MD 21 Worthen Rd, Lexington, MA 02421-4835 Ph: (781) 862-1620 |
News Archive
Genetics researchers have identified a key gene that, when mutated, causes the rare multisystem disorder Cornelia deLange syndrome (CdLS). By revealing how mutations in the HDAC8 gene disrupt the biology of proteins that control both gene expression and cell division, the research sheds light on this disease, which causes intellectual disability, limb deformations and other disabilities resulting from impairments in early development.
The Hill reports that delaying a scheduled pay cut for one year to doctors who treat Medicare patients would cost $25 billion.
Insomnia is a common problem in patients with schizophrenia, and a new study reinforces a close association between insomnia, more suicidal thoughts and actions and increased problems like anxiety and depression in these patients.
Following media reports of children with epilepsies reportedly deriving benefits from medical marijuana (or cannabis-based medicinal products) accessed abroad, the UK government allowed clinicians to prescribe these products.
Allergan plc, a leading global pharmaceutical company, today announced that its wholly owned subsidiary has entered into an exclusive licensing agreement with Mimetogen Pharmaceuticals, a clinical stage biotechnology company, to develop and commercialize tavilermide (MIM-D3), a topical formulation of a novel small molecule TrkA agonist for the treatment of dry eye disease.
› Verified 9 days ago
Daniel W Tolpin, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 21 Worthen Rd, Lexington, MA 02421 Phone: 781-862-1620 | |
Dr. Nancy S Slater, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 48 North St, Lexington, MA 02420 Phone: 781-862-7893 Fax: 781-862-7893 | |
Dr. Olivia Liao, MD Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 21 Worthen Rd, Lexington, MA 02421 Phone: 781-862-1620 Fax: 781-863-9416 | |
Kenneth Matthew Mckay, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 110 Hartwell Ave Ste 101, Lexington, MA 02421 Phone: 781-890-1023 | |
Dr. Ann Pawlowski Burnham, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 21 Worthen Rd, Lexington, MA 02421 Phone: 781-862-1620 Fax: 781-863-9416 | |
Dr. Jennifer Mullon, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 21 Worthen Rd, Lexington, MA 02421 Phone: 781-862-1620 |